"Being highly active against drug-resistant strains of M. tuberculosis, this novel class of drugs provides us with an excellent opportunity to treat tuberculosis," said lead researcher Stewart Cole. In addition, when the scientists tested Lansoprazole against a wide range of other bacteria, it proved to be highly selective for M. tuberculosis, said the study published in the journal Nature Communications.
Read More...